Vical (VICL) to Receive $4M Under New Contract to Supply Plasmid DNA for HIV Vaccine Trials
Tweet Send to a Friend
Vical Incorporated (Nasdaq: VICL) today announced that it has entered into a $4 million contract with the IPPOX Foundation to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
